Houchun Hu
Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging | 67 | 2022 | 3128 | 7.760 |
Why?
| Adipose Tissue, Brown | 25 | 2021 | 68 | 6.060 |
Why?
| Imaging, Three-Dimensional | 21 | 2021 | 538 | 4.090 |
Why?
| Image Enhancement | 19 | 2020 | 181 | 3.190 |
Why?
| Adipose Tissue | 19 | 2021 | 558 | 2.800 |
Why?
| Image Interpretation, Computer-Assisted | 17 | 2020 | 243 | 2.590 |
Why?
| Magnetic Resonance Angiography | 15 | 2019 | 240 | 2.270 |
Why?
| Artifacts | 10 | 2020 | 123 | 1.960 |
Why?
| Contrast Media | 16 | 2019 | 369 | 1.860 |
Why?
| Cerebrovascular Circulation | 5 | 2021 | 225 | 1.750 |
Why?
| Magnetic Resonance Spectroscopy | 9 | 2019 | 482 | 1.720 |
Why?
| Brain | 9 | 2019 | 2378 | 1.610 |
Why?
| Adipose Tissue, White | 6 | 2019 | 33 | 1.490 |
Why?
| Elasticity Imaging Techniques | 4 | 2019 | 44 | 1.430 |
Why?
| Adiposity | 9 | 2023 | 467 | 1.390 |
Why?
| Body Water | 9 | 2014 | 28 | 1.360 |
Why?
| Algorithms | 12 | 2021 | 1488 | 1.290 |
Why?
| Neuroimaging | 3 | 2019 | 251 | 1.270 |
Why?
| Echo-Planar Imaging | 3 | 2019 | 17 | 1.260 |
Why?
| Phantoms, Imaging | 15 | 2021 | 137 | 1.240 |
Why?
| Image Processing, Computer-Assisted | 12 | 2021 | 699 | 1.200 |
Why?
| Diffusion Magnetic Resonance Imaging | 2 | 2019 | 85 | 1.160 |
Why?
| Water | 10 | 2021 | 410 | 1.150 |
Why?
| Liver Cirrhosis | 2 | 2019 | 238 | 1.130 |
Why?
| Reproducibility of Results | 26 | 2021 | 2806 | 1.110 |
Why?
| Positron-Emission Tomography | 10 | 2019 | 275 | 1.090 |
Why?
| Liver | 12 | 2021 | 1688 | 1.070 |
Why?
| Obesity | 11 | 2019 | 2525 | 0.960 |
Why?
| Gadolinium | 3 | 2017 | 78 | 0.940 |
Why?
| Child | 42 | 2023 | 18468 | 0.930 |
Why?
| Tomography, X-Ray Computed | 12 | 2019 | 2344 | 0.930 |
Why?
| Subtraction Technique | 4 | 2012 | 28 | 0.920 |
Why?
| Diffusion Tensor Imaging | 4 | 2019 | 66 | 0.920 |
Why?
| Protons | 7 | 2021 | 80 | 0.890 |
Why?
| Infant | 21 | 2023 | 7966 | 0.880 |
Why?
| Gadolinium DTPA | 7 | 2016 | 54 | 0.880 |
Why?
| Adolescent | 37 | 2022 | 17889 | 0.830 |
Why?
| Nomograms | 1 | 2022 | 42 | 0.820 |
Why?
| Metabolic Diseases | 2 | 2021 | 98 | 0.810 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2022 | 51 | 0.790 |
Why?
| Infant, Newborn | 13 | 2022 | 5052 | 0.770 |
Why?
| Humans | 102 | 2023 | 115221 | 0.770 |
Why?
| Child, Preschool | 19 | 2021 | 9124 | 0.760 |
Why?
| White Matter | 2 | 2019 | 104 | 0.740 |
Why?
| Sensitivity and Specificity | 21 | 2019 | 1717 | 0.740 |
Why?
| Fatty Liver | 2 | 2021 | 217 | 0.700 |
Why?
| Cerebellar Nuclei | 2 | 2016 | 11 | 0.670 |
Why?
| Globus Pallidus | 2 | 2016 | 19 | 0.670 |
Why?
| Peripheral Nervous System | 1 | 2019 | 18 | 0.650 |
Why?
| Male | 54 | 2022 | 55813 | 0.650 |
Why?
| Brain Diseases | 2 | 2019 | 127 | 0.650 |
Why?
| Female | 56 | 2022 | 59719 | 0.630 |
Why?
| Spine | 2 | 2017 | 139 | 0.630 |
Why?
| Atrial Fibrillation | 1 | 2022 | 325 | 0.630 |
Why?
| Spinal Diseases | 1 | 2019 | 44 | 0.630 |
Why?
| Musculoskeletal System | 1 | 2019 | 44 | 0.630 |
Why?
| Cerebral Arteries | 1 | 2018 | 56 | 0.610 |
Why?
| Young Adult | 20 | 2021 | 10519 | 0.610 |
Why?
| Cerebrovascular Disorders | 1 | 2018 | 83 | 0.600 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2019 | 26 | 0.600 |
Why?
| Pattern Recognition, Automated | 2 | 2015 | 70 | 0.600 |
Why?
| Spin Labels | 4 | 2019 | 48 | 0.600 |
Why?
| Percutaneous Coronary Intervention | 1 | 2022 | 445 | 0.570 |
Why?
| Muscle, Skeletal | 5 | 2021 | 1477 | 0.570 |
Why?
| Central Nervous System | 1 | 2019 | 239 | 0.570 |
Why?
| Acetazolamide | 1 | 2016 | 31 | 0.550 |
Why?
| Arteries | 2 | 2016 | 249 | 0.530 |
Why?
| Motion | 6 | 2020 | 96 | 0.520 |
Why?
| Angiography | 1 | 2016 | 177 | 0.520 |
Why?
| Prediabetic State | 4 | 2021 | 224 | 0.500 |
Why?
| Multimodal Imaging | 6 | 2019 | 98 | 0.500 |
Why?
| Prospective Studies | 14 | 2023 | 6245 | 0.500 |
Why?
| Intra-Abdominal Fat | 6 | 2023 | 83 | 0.470 |
Why?
| Body Mass Index | 7 | 2022 | 1968 | 0.470 |
Why?
| Abdomen | 3 | 2020 | 104 | 0.470 |
Why?
| Feasibility Studies | 9 | 2022 | 744 | 0.460 |
Why?
| Puberty | 2 | 2012 | 137 | 0.450 |
Why?
| Fats | 2 | 2010 | 12 | 0.440 |
Why?
| Hypothermia | 1 | 2013 | 39 | 0.430 |
Why?
| Meningomyelocele | 1 | 2013 | 57 | 0.430 |
Why?
| Spinal Dysraphism | 1 | 2013 | 43 | 0.420 |
Why?
| Hypothermia, Induced | 1 | 2013 | 69 | 0.420 |
Why?
| Pancreas | 3 | 2013 | 280 | 0.390 |
Why?
| Pediatric Obesity | 4 | 2023 | 493 | 0.380 |
Why?
| Pediatrics | 1 | 2019 | 986 | 0.380 |
Why?
| Forecasting | 1 | 2012 | 333 | 0.360 |
Why?
| Complex Mixtures | 1 | 2010 | 12 | 0.350 |
Why?
| Adult | 22 | 2021 | 30710 | 0.340 |
Why?
| Thermogenesis | 3 | 2014 | 40 | 0.340 |
Why?
| Patella | 3 | 2014 | 25 | 0.330 |
Why?
| Neurons | 2 | 2016 | 1285 | 0.330 |
Why?
| Cystic Fibrosis | 1 | 2018 | 957 | 0.330 |
Why?
| Retrospective Studies | 11 | 2022 | 12596 | 0.320 |
Why?
| Biopsy | 3 | 2013 | 1050 | 0.320 |
Why?
| Abdominal Fat | 4 | 2023 | 43 | 0.310 |
Why?
| Carotid Arteries | 3 | 2010 | 183 | 0.310 |
Why?
| Bone Marrow | 2 | 2021 | 248 | 0.300 |
Why?
| Whole Body Imaging | 2 | 2019 | 23 | 0.300 |
Why?
| Fluoroscopy | 2 | 2005 | 141 | 0.300 |
Why?
| Veins | 1 | 2008 | 57 | 0.300 |
Why?
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 69 | 0.290 |
Why?
| Cerebral Veins | 1 | 2007 | 16 | 0.280 |
Why?
| Data Compression | 3 | 2013 | 8 | 0.280 |
Why?
| Leg | 2 | 2006 | 228 | 0.280 |
Why?
| Subcutaneous Fat | 4 | 2019 | 71 | 0.260 |
Why?
| Respiratory Mechanics | 1 | 2005 | 57 | 0.250 |
Why?
| Radiography, Interventional | 1 | 2005 | 111 | 0.240 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2016 | 123 | 0.240 |
Why?
| Body Weight | 3 | 2014 | 875 | 0.240 |
Why?
| Animals | 12 | 2019 | 31884 | 0.210 |
Why?
| Linear Models | 3 | 2013 | 779 | 0.210 |
Why?
| Age Determination by Skeleton | 1 | 2022 | 18 | 0.200 |
Why?
| Heart Atria | 1 | 2022 | 111 | 0.200 |
Why?
| Accountable Care Organizations | 1 | 2021 | 14 | 0.190 |
Why?
| Running | 2 | 2014 | 209 | 0.190 |
Why?
| Neonatal Abstinence Syndrome | 1 | 2021 | 14 | 0.190 |
Why?
| Body Temperature | 2 | 2013 | 210 | 0.190 |
Why?
| Brain Neoplasms | 2 | 2019 | 984 | 0.190 |
Why?
| Anthropometry | 2 | 2013 | 182 | 0.190 |
Why?
| Insulin Resistance | 5 | 2022 | 1079 | 0.190 |
Why?
| Least-Squares Analysis | 2 | 2012 | 73 | 0.180 |
Why?
| Lumbosacral Plexus | 1 | 2020 | 7 | 0.180 |
Why?
| Fractures, Stress | 1 | 2020 | 32 | 0.180 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2022 | 2098 | 0.180 |
Why?
| Respiratory-Gated Imaging Techniques | 1 | 2020 | 11 | 0.180 |
Why?
| Intensive Care Units, Neonatal | 1 | 2022 | 177 | 0.170 |
Why?
| Risk | 1 | 2022 | 816 | 0.170 |
Why?
| Switzerland | 1 | 2019 | 18 | 0.170 |
Why?
| Netherlands | 1 | 2019 | 65 | 0.170 |
Why?
| Japan | 1 | 2019 | 88 | 0.170 |
Why?
| Germany | 1 | 2019 | 85 | 0.170 |
Why?
| Moyamoya Disease | 1 | 2019 | 15 | 0.170 |
Why?
| Thermography | 1 | 2019 | 12 | 0.170 |
Why?
| Electrocardiography | 1 | 2022 | 563 | 0.170 |
Why?
| Tibial Fractures | 1 | 2020 | 70 | 0.170 |
Why?
| Myocardial Perfusion Imaging | 2 | 2010 | 37 | 0.170 |
Why?
| Calorimetry | 1 | 2019 | 61 | 0.170 |
Why?
| Anisotropy | 1 | 2019 | 62 | 0.170 |
Why?
| Radiation Exposure | 1 | 2019 | 41 | 0.160 |
Why?
| Lung Diseases | 1 | 2005 | 703 | 0.160 |
Why?
| Overweight | 2 | 2013 | 475 | 0.160 |
Why?
| Absorptiometry, Photon | 1 | 2019 | 223 | 0.160 |
Why?
| Canada | 1 | 2019 | 323 | 0.160 |
Why?
| Metabolome | 1 | 2021 | 285 | 0.160 |
Why?
| Speech Perception | 1 | 2019 | 80 | 0.160 |
Why?
| Gray Matter | 1 | 2019 | 68 | 0.160 |
Why?
| Migraine Disorders | 1 | 2019 | 83 | 0.150 |
Why?
| Neural Pathways | 1 | 2019 | 259 | 0.150 |
Why?
| Organ Size | 2 | 2016 | 444 | 0.150 |
Why?
| Software | 1 | 2022 | 538 | 0.150 |
Why?
| Anesthesia, General | 1 | 2018 | 45 | 0.150 |
Why?
| Spasms, Infantile | 1 | 2019 | 104 | 0.150 |
Why?
| Anesthetics | 1 | 2018 | 56 | 0.150 |
Why?
| Conscious Sedation | 1 | 2018 | 79 | 0.140 |
Why?
| Swine | 2 | 2010 | 705 | 0.140 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2016 | 18 | 0.140 |
Why?
| Patient Selection | 1 | 2020 | 651 | 0.140 |
Why?
| Recovery of Function | 1 | 2020 | 577 | 0.140 |
Why?
| Phlebography | 2 | 2008 | 40 | 0.140 |
Why?
| Seizures | 1 | 2019 | 341 | 0.140 |
Why?
| Monitoring, Physiologic | 1 | 2018 | 249 | 0.140 |
Why?
| Culturally Competent Care | 1 | 2017 | 49 | 0.130 |
Why?
| Musculoskeletal Development | 2 | 2013 | 4 | 0.130 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 1214 | 0.120 |
Why?
| Emotions | 1 | 2019 | 473 | 0.120 |
Why?
| Thalamus | 1 | 2015 | 75 | 0.120 |
Why?
| Age Factors | 4 | 2019 | 2900 | 0.120 |
Why?
| Brain Injuries, Traumatic | 1 | 2019 | 301 | 0.120 |
Why?
| Behavior Therapy | 1 | 2017 | 227 | 0.120 |
Why?
| Respiration | 2 | 2019 | 182 | 0.120 |
Why?
| Research Design | 1 | 2020 | 933 | 0.120 |
Why?
| Guidelines as Topic | 1 | 2016 | 246 | 0.120 |
Why?
| Patellofemoral Pain Syndrome | 1 | 2014 | 7 | 0.120 |
Why?
| Analgesics, Opioid | 1 | 2021 | 774 | 0.120 |
Why?
| Liver Diseases | 1 | 2017 | 263 | 0.120 |
Why?
| Bone Density | 2 | 2021 | 432 | 0.120 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 246 | 0.120 |
Why?
| Athletic Injuries | 1 | 2020 | 457 | 0.120 |
Why?
| Neck | 1 | 2014 | 84 | 0.120 |
Why?
| Biomarkers | 3 | 2021 | 3422 | 0.120 |
Why?
| Recreation | 1 | 2014 | 23 | 0.110 |
Why?
| Middle Aged | 9 | 2019 | 26872 | 0.110 |
Why?
| Hypothyroidism | 1 | 2014 | 66 | 0.110 |
Why?
| Patellofemoral Joint | 1 | 2013 | 9 | 0.110 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2014 | 81 | 0.110 |
Why?
| Mice | 5 | 2013 | 14934 | 0.110 |
Why?
| Arthralgia | 1 | 2013 | 50 | 0.110 |
Why?
| Body Composition | 2 | 2015 | 586 | 0.110 |
Why?
| Scapula | 1 | 2013 | 41 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2020 | 909 | 0.100 |
Why?
| Ion Channels | 1 | 2012 | 124 | 0.100 |
Why?
| Mice, Obese | 1 | 2012 | 54 | 0.100 |
Why?
| Lipids | 1 | 2015 | 587 | 0.100 |
Why?
| Cadaver | 1 | 2013 | 311 | 0.100 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 4419 | 0.090 |
Why?
| Reward | 1 | 2013 | 212 | 0.090 |
Why?
| Muscle Strength | 1 | 2013 | 271 | 0.090 |
Why?
| Lymphoma | 1 | 2012 | 178 | 0.090 |
Why?
| Femur | 1 | 2012 | 193 | 0.090 |
Why?
| Homeostasis | 1 | 2014 | 578 | 0.090 |
Why?
| Cues | 1 | 2013 | 302 | 0.090 |
Why?
| Mitochondrial Proteins | 1 | 2012 | 220 | 0.090 |
Why?
| Lower Extremity | 1 | 2014 | 337 | 0.090 |
Why?
| Energy Intake | 1 | 2013 | 420 | 0.090 |
Why?
| Eating | 1 | 2013 | 347 | 0.090 |
Why?
| Prognosis | 2 | 2019 | 3336 | 0.090 |
Why?
| Movement | 2 | 2020 | 246 | 0.090 |
Why?
| Severity of Illness Index | 2 | 2014 | 2552 | 0.090 |
Why?
| Prevalence | 2 | 2019 | 2257 | 0.090 |
Why?
| Emulsions | 1 | 2010 | 43 | 0.090 |
Why?
| Aging | 1 | 2019 | 1624 | 0.090 |
Why?
| Blood | 1 | 2010 | 97 | 0.080 |
Why?
| Ankle Joint | 1 | 2011 | 154 | 0.080 |
Why?
| California | 1 | 2010 | 364 | 0.080 |
Why?
| Energy Metabolism | 1 | 2014 | 730 | 0.080 |
Why?
| Child Development | 1 | 2013 | 388 | 0.080 |
Why?
| Chi-Square Distribution | 2 | 2012 | 498 | 0.080 |
Why?
| Reference Values | 3 | 2017 | 748 | 0.080 |
Why?
| Magnetic Resonance Imaging, Cine | 1 | 2010 | 183 | 0.080 |
Why?
| Analysis of Variance | 1 | 2012 | 1231 | 0.080 |
Why?
| Coronary Circulation | 1 | 2008 | 135 | 0.080 |
Why?
| Knee Joint | 1 | 2011 | 324 | 0.080 |
Why?
| Cerebral Angiography | 1 | 2008 | 111 | 0.080 |
Why?
| United States | 2 | 2021 | 12256 | 0.080 |
Why?
| Neoplasms | 2 | 2012 | 2106 | 0.070 |
Why?
| Popliteal Artery | 2 | 2006 | 59 | 0.070 |
Why?
| Temperature | 2 | 2021 | 578 | 0.070 |
Why?
| Myocardial Ischemia | 1 | 2008 | 237 | 0.070 |
Why?
| In Vitro Techniques | 1 | 2008 | 1036 | 0.070 |
Why?
| Cohort Studies | 2 | 2019 | 4917 | 0.070 |
Why?
| Blood Flow Velocity | 2 | 2005 | 395 | 0.070 |
Why?
| Fourier Analysis | 1 | 2006 | 41 | 0.070 |
Why?
| Radiation Monitoring | 1 | 2005 | 6 | 0.070 |
Why?
| Radiography | 2 | 2022 | 827 | 0.060 |
Why?
| Radiography, Abdominal | 1 | 2005 | 33 | 0.060 |
Why?
| Regression Analysis | 3 | 2012 | 949 | 0.060 |
Why?
| Bone and Bones | 2 | 2022 | 282 | 0.060 |
Why?
| Equipment Failure Analysis | 1 | 2005 | 135 | 0.060 |
Why?
| Statistics, Nonparametric | 1 | 2005 | 387 | 0.060 |
Why?
| Radiography, Thoracic | 1 | 2005 | 163 | 0.060 |
Why?
| Radiation Dosage | 1 | 2005 | 138 | 0.060 |
Why?
| Tibial Arteries | 1 | 2004 | 13 | 0.060 |
Why?
| Renal Artery | 1 | 2004 | 26 | 0.060 |
Why?
| Feeding Behavior | 2 | 2023 | 574 | 0.060 |
Why?
| Injections, Intravenous | 1 | 2004 | 202 | 0.060 |
Why?
| Equipment Design | 1 | 2005 | 513 | 0.060 |
Why?
| Myocardium | 1 | 2008 | 925 | 0.060 |
Why?
| Femoral Artery | 1 | 2004 | 168 | 0.050 |
Why?
| Longitudinal Studies | 2 | 2023 | 2388 | 0.050 |
Why?
| Singapore | 1 | 2021 | 15 | 0.050 |
Why?
| Growth Disorders | 1 | 2022 | 78 | 0.050 |
Why?
| Time Factors | 2 | 2019 | 6157 | 0.050 |
Why?
| Neurologic Examination | 1 | 2021 | 115 | 0.050 |
Why?
| Obesity, Abdominal | 1 | 2021 | 38 | 0.050 |
Why?
| Sex Factors | 2 | 2019 | 1722 | 0.050 |
Why?
| Hand | 1 | 2022 | 134 | 0.050 |
Why?
| Time | 1 | 2020 | 71 | 0.040 |
Why?
| Trauma Severity Indices | 1 | 2020 | 111 | 0.040 |
Why?
| Risk Factors | 4 | 2017 | 8658 | 0.040 |
Why?
| Voice | 1 | 2019 | 9 | 0.040 |
Why?
| Perfusion Imaging | 1 | 2019 | 55 | 0.040 |
Why?
| Computer Simulation | 2 | 2016 | 879 | 0.040 |
Why?
| Aspartic Acid | 1 | 2019 | 78 | 0.040 |
Why?
| Wavelet Analysis | 1 | 2019 | 7 | 0.040 |
Why?
| Tibia | 1 | 2020 | 169 | 0.040 |
Why?
| Signal-To-Noise Ratio | 1 | 2019 | 57 | 0.040 |
Why?
| Aged | 4 | 2017 | 19135 | 0.040 |
Why?
| Outpatients | 1 | 2021 | 329 | 0.040 |
Why?
| Life Style | 1 | 2020 | 431 | 0.040 |
Why?
| Medicaid | 1 | 2021 | 411 | 0.040 |
Why?
| Athletes | 1 | 2020 | 324 | 0.040 |
Why?
| Publication Bias | 1 | 2017 | 37 | 0.040 |
Why?
| Healthy Lifestyle | 1 | 2017 | 29 | 0.030 |
Why?
| Metabolic Syndrome | 1 | 2019 | 324 | 0.030 |
Why?
| Brain Ischemia | 1 | 2019 | 297 | 0.030 |
Why?
| Motivation | 1 | 2020 | 498 | 0.030 |
Why?
| Brain Mapping | 1 | 2019 | 523 | 0.030 |
Why?
| Cell Nucleus | 1 | 2019 | 556 | 0.030 |
Why?
| Clinical Protocols | 1 | 2017 | 234 | 0.030 |
Why?
| Clinical Competence | 1 | 2022 | 904 | 0.030 |
Why?
| Statistics as Topic | 1 | 2016 | 298 | 0.030 |
Why?
| Risk Reduction Behavior | 1 | 2017 | 201 | 0.030 |
Why?
| Predictive Value of Tests | 2 | 2011 | 1816 | 0.030 |
Why?
| Databases, Factual | 1 | 2019 | 1136 | 0.030 |
Why?
| Infrared Rays | 1 | 2014 | 21 | 0.030 |
Why?
| Lipid Metabolism | 1 | 2017 | 449 | 0.030 |
Why?
| Mice, Inbred C57BL | 2 | 2013 | 4718 | 0.030 |
Why?
| Rest | 1 | 2013 | 105 | 0.030 |
Why?
| Physical Examination | 1 | 2014 | 221 | 0.030 |
Why?
| Hunger | 1 | 2013 | 38 | 0.030 |
Why?
| Appetite | 1 | 2013 | 53 | 0.030 |
Why?
| Myogenic Regulatory Factor 5 | 1 | 2012 | 5 | 0.030 |
Why?
| Uncoupling Protein 1 | 1 | 2012 | 16 | 0.030 |
Why?
| Waist Circumference | 1 | 2013 | 123 | 0.030 |
Why?
| Disease | 1 | 2013 | 86 | 0.030 |
Why?
| Microarray Analysis | 1 | 2012 | 119 | 0.030 |
Why?
| Patient Care Team | 1 | 2017 | 516 | 0.030 |
Why?
| Diatrizoate Meglumine | 1 | 2012 | 3 | 0.030 |
Why?
| Abdominal Muscles | 1 | 2012 | 6 | 0.030 |
Why?
| Durapatite | 1 | 2012 | 32 | 0.030 |
Why?
| Bone Development | 1 | 2012 | 48 | 0.030 |
Why?
| Calibration | 1 | 2012 | 126 | 0.030 |
Why?
| Postprandial Period | 1 | 2012 | 88 | 0.030 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2012 | 172 | 0.020 |
Why?
| Thiazolidinediones | 1 | 2012 | 143 | 0.020 |
Why?
| Pain Measurement | 1 | 2013 | 448 | 0.020 |
Why?
| PPAR gamma | 1 | 2012 | 184 | 0.020 |
Why?
| Lung | 1 | 2003 | 3595 | 0.020 |
Why?
| Emergency Service, Hospital | 1 | 2021 | 1811 | 0.020 |
Why?
| Diet, Reducing | 1 | 2011 | 79 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 746 | 0.020 |
Why?
| Risk Assessment | 1 | 2019 | 2981 | 0.020 |
Why?
| Trans-Activators | 1 | 2012 | 368 | 0.020 |
Why?
| Age Distribution | 1 | 2011 | 341 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 337 | 0.020 |
Why?
| Pregnancy | 1 | 2021 | 5525 | 0.020 |
Why?
| Pilot Projects | 1 | 2014 | 1377 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2011 | 344 | 0.020 |
Why?
| Models, Cardiovascular | 1 | 2010 | 180 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 603 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2012 | 1635 | 0.020 |
Why?
| Ecosystem | 1 | 2013 | 517 | 0.020 |
Why?
| Nuclear Proteins | 1 | 2012 | 593 | 0.020 |
Why?
| Glucocorticoids | 1 | 2012 | 539 | 0.020 |
Why?
| Models, Theoretical | 1 | 2011 | 517 | 0.020 |
Why?
| Logistic Models | 1 | 2012 | 1841 | 0.020 |
Why?
| Insulin-Secreting Cells | 1 | 2011 | 318 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6358 | 0.020 |
Why?
| Supine Position | 1 | 2006 | 34 | 0.020 |
Why?
| Quality of Life | 1 | 2017 | 2364 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 2012 | 1318 | 0.020 |
Why?
| Models, Biological | 1 | 2012 | 1638 | 0.020 |
Why?
| Transcription Factors | 1 | 2012 | 1531 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2012 | 4430 | 0.010 |
Why?
| Treatment Outcome | 1 | 2017 | 9151 | 0.010 |
Why?
| Feedback | 1 | 2003 | 146 | 0.010 |
Why?
| Exercise | 1 | 2011 | 1644 | 0.010 |
Why?
| Physician-Patient Relations | 1 | 2003 | 463 | 0.010 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|